Arthur J. Falk, PhD, is president and CDO of International Pharmaceutical Excipient Auditing (IPEA).
Inside IPEC: Excipient Pedigree as a Supply Chain Tool
It's time to maintain a thorough traceable excipient trail.
Excipient-Control Strategies
Securing the integrity of the excipient supply chain is a crucial task in ensuring the overall pharmaceutical supply chain. The authors outline excipient-control strategies and practices for the manufacture, distribution, and receipt of excipients.
The Bioterrorism Act
Two FDA final rules issued in response to the Bioterrorism Response Act of 2002 may significantly affect the supply and importation of pharmaceutical excipients.